NCT03806582

Brief Summary

Right ventricular (RV) dysfunction in cardiac surgery is an independent risk factor for morbidity and mortality. Raising the systemic blood pressure with norepinephrine seems to have a positive influence on the right ventricular function in several animal studies. The current study is designed to evaluate the effect of a higher blood pressure on the RV function in post cardiac surgery patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 16, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2020

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2020

Completed
Last Updated

May 27, 2020

Status Verified

May 1, 2020

Enrollment Period

1.2 years

First QC Date

October 29, 2018

Last Update Submit

May 25, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • right ventricular ejection fraction

    Primary endpoint is the difference between the intervention and the control group in the change over time between baseline and the end of the study period (T4) in RVEF.

    2 hours postoperative

Secondary Outcomes (4)

  • Echocardiographic

    2 hours postoperative

  • RV end-diastolic pressure

    baseline and 15 minutes postoperatively

  • Cardiac index

    2 hours postoperative

  • Fluid balance

    2 hours postoperative

Study Arms (2)

intervention

ACTIVE COMPARATOR

intervention with norepinephrine to reach a MAP of 85 mmHg for a maximum duration of 1 hour, observation of the effect on right ventricular function

Drug: Norepinephrine

control

NO INTERVENTION

control group; treatment according to current standards, observation of the effect on right ventricular function

Interventions

intervention with norepinephrine to reach a MAP of 85 mmHg

intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • post operative cardiac surgery patients, full sternotomy
  • admission at ICU
  • informed consent
  • right ventricular monitoring by pulmonary artery catheter.
  • RVEF \<30% + MAP ≤ 65mmHg

You may not qualify if:

  • no informed consent
  • acute surgery
  • Off pump cardiac surgery
  • Severe tricuspid insufficiency
  • Allergy to norepinephrine
  • Severe left ventricular hypertrophy with systolic anterior movement
  • Chronic use of alpha-blockers
  • Irregulair heart rhythm
  • Surgical reasons to maintain a low blood pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Center Leeuwarden

Leeuwarden, 8904 BR, Netherlands

Location

MeSH Terms

Conditions

Ventricular Dysfunction, Right

Interventions

Norepinephrine

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Officials

  • Christiaan Boerma, Dr

    Frisius Medisch Centrum

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Masking Details
open label study
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

October 29, 2018

First Posted

January 16, 2019

Study Start

March 1, 2019

Primary Completion

May 15, 2020

Study Completion

May 25, 2020

Last Updated

May 27, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations